Pressmeddelande
Invitation to presentation of MEDS Q3 2025 Interim Report on November 7, 2025
MEDS will publish its interim report for the third quarter of 2025 on November 7, 2025, at 07:30 CET. A webcast presentation will be held at: https://www.finwire.tv/webcast/meds-apotek/meds-2025/ for analysts, media, and investors at 10:00 CET the same day.
The report will be presented by Björn Thorngren, CEO and co-founder, and Nick Mendola, CFO.
The presentation will be conducted in English and broadcast live online. To register please email [email protected] at latest 09.00 CET on November 7, 2025.
A recorded version of the presentation will also be available at: https://www.finwire.tv/webcast/meds-apotek/meds-2025/
Phone number for analysts: +46850163827, then enter the meeting ID: 81972913787 followed by #
Schedule on the 7th of November:
- 07:30 CET – Publication of the Q3 report
- 10:00 CET – Webcast and conference call with CEO Björn Thorngren and CFO Nick Mendola
For further information, please contact:
Frida Benno Hjerpe
MEDS Press & Investor Relations
E-mail: [email protected]
Web: https://corporate.meds.se/
About MEDS
MEDS.se is a full-scale online pharmacy licensed by the Swedish Medical Products Agency. We provide both prescription and over-the-counter medicines for you, your family, and your pets.
In addition, MEDS offers a wide range of products in health, beauty, and wellness.
Certified advisor is FNCA.